# FDA Inspection 1040192 - CTL Medical Corporation - January 18, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/ctl-medical-corporation/b2d82643-5695-4e06-8fbc-759fdaa0613b
Source feed: FDA_Inspections

> FDA Inspection 1040192 for CTL Medical Corporation on January 18, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040192
- Company Name: CTL Medical Corporation
- Inspection Date: 2018-01-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269610 - 2025-05-01](https://www.globalkeysolutions.net/records/fda_inspections/ctl-medical-corporation/8719eee7-5449-47e3-9457-8793c890192d)
- [FDA Inspection 1269610 - 2025-05-01](https://www.globalkeysolutions.net/records/fda_inspections/ctl-medical-corporation/b47ea15b-48c0-48b8-804f-11969e8b0a9c)
- [FDA Inspection 1269610 - 2025-05-01](https://www.globalkeysolutions.net/records/fda_inspections/ctl-medical-corporation/f471e0b1-ddba-40bf-a4a3-5e2bf79c7ab3)
- [FDA Inspection 860322 - 2013-12-04](https://www.globalkeysolutions.net/records/fda_inspections/ctl-medical-corporation/d74598f1-698c-4954-a935-e0a55f0b3151)

Company: https://www.globalkeysolutions.net/companies/ctl-medical-corporation/a6e64680-dbcc-4cd8-beba-7405cdbcd9ff

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d